Activation of Intestinal Epithelial Stat3 Orchestrates Tissue Defense during Gastrointestinal Infection

Nadine Wittkopf; Geethanjali Pickert; Ulrike Billmeier; Mousumi Mahapatro; Stefan Wirtz; Eva Martini; Moritz Leppkes; Markus Friedrich Neurath; Christoph Becker

doi:10.1371/journal.pone.0118401

Abstract

Gastrointestinal infections with EHEC and EPEC are responsible for outbreaks of diarrheal diseases and represent a global health problem. Innate first-line-defense mechanisms such as production of mucus and antimicrobial peptides by intestinal epithelial cells are of utmost importance for host control of gastrointestinal infections. For the first time, we directly demonstrate a critical role for Stat3 activation in intestinal epithelial cells upon infection of mice with Citrobacter rodentium – a murine pathogen that mimics human infections with attaching and effacing Escherichia coli. C. rodentium induced transcription of IL-6 and IL-22 in gut samples of mice and was associated with activation of the transcription factor Stat3 in intestinal epithelial cells. C. rodentium infection induced expression of several antimicrobial peptides such as RegIIIγ and Pla2g2a in the intestine which was critically dependent on Stat3 activation. Consequently, mice with specific deletion of Stat3 in intestinal epithelial cells showed increased susceptibility to C. rodentium infection as indicated by high bacterial load, severe gut inflammation, pronounced intestinal epithelial cell death and dissemination of bacteria to distant organs. Together, our data implicate an essential role for Stat3 activation in intestinal epithelial cells during C. rodentium infection. Stat3 concerts the host response to bacterial infection by controlling bacterial growth and suppression of apoptosis to maintain intestinal epithelial barrier function.

Citation: Wittkopf N, Pickert G, Billmeier U, Mahapatro M, Wirtz S, Martini E, et al. (2015) Activation of Intestinal Epithelial Stat3 Orchestrates Tissue Defense during Gastrointestinal Infection. PLoS ONE 10(3): e0118401. https://doi.org/10.1371/journal.pone.0118401

Academic Editor: Bernhard Ryffel, French National Centre for Scientific Research, FRANCE

Received: October 31, 2014; Accepted: December 14, 2014; Published: March 23, 2015

Copyright: © 2015 Wittkopf et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Data Availability: All relevant data are within the paper.

Funding: The research leading to these results has received funding from the Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg, the European Community's 7th Framework Program (acronym BTCure), and the DFG (SFB796, SPP1656, clinical research unit KFO257). NW was further supported by DFG grant BE3686/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Bacterial infections of the gastrointestinal tract are a frequent cause of diarrhea followed by dehydration and are estimated to cause 2.5 million deaths per year, especially in underdeveloped countries [1]. Among the diarrhea-inducing bacteria, pathogenic Escherichia coli such as enteropathogenic E. coli (EPEC) and enterohaemorrhagic E. coli (EHEC) frequently cause outbreaks of diarrheal diseases [2, 3]. The largest outbreak of EHEC infection ever seen in Europe occurred in Germany in spring 2011: more than 2,900 cases of acute gastroenteritis, more than 850 cases of haemolytic uraemic syndrome (HUS) and at least 50 related deaths in three months were listed [4].

EHEC and EPEC infections cause non-specific gastroenteritis and the benefit of antibiotic agents for treatment of EHEC and EPEC infections is a long-standing matter of debate [5]. Not only might current antibiotics shape the natural course of the disease, but affect the pathogen as well as the beneficial commensal gut flora. Accordingly, there is an urgent need for new therapeutic approaches to combat pathogens and prevent common side-effects such as antibiotic-associated diarrhea. Interestingly, the gut itself also possesses antibacterial defense mechanisms such as antimicrobial peptides (AMPs) produced by specialized intestinal epithelial cells, designated Paneth cells [6, 7]. Therefore, studies make efforts to investigate the role of AMPs during infections with intestinal pathogens. For example, mice overexpressing the antimicrobial peptide CRAMP (cathelicidin-related antimicrobial peptide) were demonstrated to be protected from oral infection with Citrobacter rodentium (C. rodentium) [8], a naturally occurring mouse pathogen that is commonly used to mimic human infections with EHEC and EPEC.

The body’s own antimicrobial defense mechanisms in the gut are of utmost importance for maintenance of a healthy intestine. Using a mouse model of inflammatory bowel disease, we recently suggested a role of Stat3 (signal transducer and activator of transcription 3) activation in intestinal epithelial cells (IECs) for tissue homeostasis. Interestingly, among the genes which were differentially regulated in Stat3 deficient IECs, several were previously reported to show antimicrobial functions. Consequently, Gene Ontology analysis indicated that Stat3 might be involved in antimicrobial defense [9]. Stat3 is a transcription factor whose increased activation in colonic epithelial cells has been observed in some patients with active inflammatory bowel disease (IBD) [10, 11]. Moreover, genome-wide association studies have linked polymorphisms in the allele encoding Stat3 with an increased risk for the development of IBD [12, 13]. Stat3 is activated by binding of certain ligands such as IL-6, IL-10 and IL-11 to their specific receptors; activated Stat3 then transfers to the nucleus and induces the transcription of target genes including BCL2, MYC and BIRC5. It has recently been demonstrated that IL-22 induces activation of Stat3 and that IL-22 is crucial for production of AMPs in the intestine [14]. Accordingly, IL-22 is important to combat most intestinal infections. While IL-22 production is increased after infection with Listeria monocytogenes, it is not required for clearance of the infection [15]. Yet, IL-22 deficient mice develop severe colitis after infection with C. rodentium and show high mortality [14]. Therefore, although IL-22 expression is increased during colitis, IL-22 is hypothesized to exert protective functions via activation of Stat3 in the intestinal epithelium. Although IL-22 has been demonstrated to protect the host from gastrointestinal infections, the functional role of Stat3 in the epithelium has not been demonstrated. Using intestinal epithelial cell specific Stat3 deficient mice (Stat3^ΔIEC), we demonstrate a critical role for Stat3 activation in IECs during C. rodentium infection. Our data show that mice unable to activate Stat3 in IECs are severely impaired in their ability to defend against C. rodentium. Mechanistical data indicate that Stat3 orchestrates the intestinal epithelial response to bacterial infection by production of antimicrobial peptides and suppression of apoptosis.

Materials and Methods

Mice

We obtained C57BL/6 wildtype mice from the animal facility of the University of Mainz. Mice carrying both loxP-flanked Stat3 alleles (Stat3^fl/fl) and the Cre-recombinase under control of the Villin-promoter were described before (Stat3^ΔIEC) [9]. All mice were housed in individually ventilated cages. To exclude an effect of different mouse microbiota in separated cages, Stat3^ΔIEC mice and control (Stat3^fl/fl) littermates were housed in mixed cages. The protocol was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by Landesuntersuchungsamt Koblenz (Permit Number: 2.3 177–07/G 07–1–006). Mouse endoscopy and IVIS analysis were performed using isoflurane anesthesia, and all efforts were made to minimize suffering.

Citrobacter rodentium infection and endoscopy

For bacteria-induced colitis, mice were infected with an erythromycin resistant and luminescent strain of Citrobacter rodentium (C. rodentium strain ICC169 was kindly provided by C. Riedel [29]). Bacteria were grown in sterile LB-Medium supplemented with 500 μg / ml erythromycin at 37°C and resuspended in sterile PBS to a final concentration of approximately 4 x 10⁹ bacteria per 200 μl. Mice were fastened for eight hours and 200 μl of bacteria suspension were given to each animal using a feeding needle. For quantification of the applied numbers of C. rodentium, the bacterial suspension was plated on CASO-blood agar plates (Heipha Dr. Müller GmbH, Eppelheim, Germany). For monitoring of luminescent C. rodentium growth and distribution in live mice, mice were anesthetized by gassing with isoflurane (1.5–2% mixed with air; Abbott).The abdomen of the mice was depilated and luminescence was measured using an IVIS Lumina II system (Caliper Life Science, Waltham, Massachusetts, USA). Quantification of luminescence was performed using the IVIS-associated software “Living Image” (Caliper Lifescience). For follow up development of colitis and endoscopic scoring, the Coloview high resolution mouse endoscopic system (Storz, Tuttlingen, Germany) was used as previously described [30]. Health of mice was monitored by weighing mice every other day. At the end of the experiments, mice were sacrificed by cervical dislocation. Tissue samples were collected and either instantly frozen in liquid nitrogen or fixed in Histofix (Roth, Karlsruhe, Germany).

Organoid culture

Small intestinal crypts were isolated and cultured as previously described by Sato et al [31]. After 6 days of organoid growth, organoids were treated with IL-22 (100 ng / ml; Peprotech, Rocky Hill, New Jersey, USA) for 24 hours or left untreated. Organoids were harvested, washed twice with PBS and embedded in Histogel (Thermo Scientific, Waltham, Massachusetts, USA) according to manufacturer’s recommendations. After solidifying, solid Histogel-organoid samples were fixed in Histofix (Roth).

Expression analysis

mRNA was isolated using the NucleoSpin RNA II kit (Macherey-Nagel, Düren, Germany) and reverse transcribed into complementary DNA using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, California, USA) as recommended by the manufacture. Quantitative PCR was performed using cDNA-specific Quantitect Primer assays (Qiagen, Hilden, Germany) and SsoFast EvaGreen Supermix (Bio-Rad) according to the manufacturer’s recommendations. Samples were either normalized to the general housekeeping gene Hprt or the intestinal epithelial housekeeping gene Villin.

Histological examination

For histological examination, frozen or dehydrated and paraffin-embedded Histofix-fixed tissues were sectioned. Sections were stained with Mayer’s haematoxylin & eosin (H & E) as recommended by the manufacturer’s protocol. For immunohistochemical analysis, frozen tissue slices were fixed on glass slides using 4% PFA and paraffin-embedded tissue sections were dewaxed and rehydrated. anti-pStat3 (Cell Signaling, Danvers, Massachusetts, USA), anti-MPO (Abcam, Cambridge, United Kingdom), anti-CD4 (BD Pharmingen, San Jose, California, USA), anti-CD11c (BD Bioscience, San Jose, California, USA) and anti-RegIIIγ (antibodies online GmbH, Aachen, Germany) were used as primary antibodies. A biotinylated secondary anti-rabbit-antibody (Dianova, Hamburg, Germany) was used together with the TSA Cy3 system (Perkin Elmer, Waltham Massachusetts, USA) in accordance with the manufacturer’s protocol. Dying cells were detected using TUNEL assay (In situ Cell death Detection Kit Fluorescein, Roche, Basel, Switzerland) as recommended by the manufacturer. Bacteria present in tissues were detected by fluorescence in situ hybridization (FISH) of bacterial RNA as previously described [32]. Nuclei were counterstained with Hoechst (Invitrogen, Darmstadt, Germany). Images were obtained using the bright-field / fluorescence microscope Olympus IX70 (Olympus, Hamburg, Germany) or Leica DMI4000 B (Leica, Wetzlar, Germany).

Statistical analysis

Statistical analysis was performed using the two-tailed student’s t-test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, n.s. = not significant. Percentages of cells in immunofluorescence pictures were calculated using ImageJ (National Institute of Health) [33].

Results

To examine the role of Stat3 for antimicrobial defense mechanisms during gastrointestinal infections in vivo, we used the C. rodentium induced infectious colitis mouse model. After oral infection of C57BL/6J wildtype mice with 4 x 10⁹ luminescent C. rodentium, the development of infection was monitored using an in vivo imaging system. In agreement with a transient infection, we observed a continuous increase in luminescence in the gut over seven days and a decrease to background levels afterwards (Fig. 1a). Endoscopic analysis of infected mice revealed signs of intestinal inflammation such as bowel-wall thickening, granularity of the mucosa, and fibrin formation (Fig. 1b). Upon screening for the expression of cytokines known to regulate intestinal defense mechanisms, IL-6 and IL-22 revealed strong induction after bacterial infection (Fig. 1c). Our finding is in line with recent data published by Zheng et al. [14], showing that IL-22 was strongly increased after C. rodentium infection. IL-22 has been reported to be produced by several cell types including dendritic cells [9], neutrophils [16], Th17 cells [17, 18] and subsets of NK cells [19, 20]. However, recent data suggest RORγt⁺ innate lymphoid cells (ILCs) to be the main producers of IL-22 in the gut [21]. Both IL-6 and IL-22 can induce the Stat3 signaling pathway in epithelial cells upon binding to their receptors. To analyze Stat3 activation in the intestinal epithelium in response to bacterial infections, gut samples from wildtype mice were harvested at different time-points and stained for phosphorylated Stat3. While colonic epithelial cells of uninfected mice showed no phosphorylated Stat3, the transcription factor was activated after infection with C. rodentium (Fig. 1d). Notably, the number of IECs showing activation of Stat3 increased with progression of infection. In striking similarity to C. rodentium derived luminescence signals, the strongest phosphorylation of Stat3 was observed around day 6. These results suggest activation of Stat3 as a biological response of the intestinal epithelium to bacterial infection.

Download:

Fig 1. Infection of wildtype mice with C. rodentium activates Stat3 in the intestinal epithelium.

A) Luminescent C. rodentium was visualized and quantified in live wildtype mice at different time points after infection using IVIS. Exemplary pictures on day three (left) and day seven (right) are shown. Data show mean values + SEM (n = 4 mice). B) Representative colonoscopy pictures demonstrate absence of colitis in unchallenged mice (top) and inflammation in the colon of C. rodentium infected mice (bottom, day six after infection). C) Transcription of Stat3-inducing cytokines in the colon of C. rodentium infected wildtype mice (n = 4) and unchallenged wildtype mice (n = 5). Gene transcription is normalized to Hprt. Data show mean values + SEM. D) Colon cross-sections of wildtype mice were stained for phosphorylated Stat3 (pStat3, red) at different time points of C. rodentium infection. Nuclei are shown in blue. Scale bars: 100 μm. The experiment was performed four times with similar results.

https://doi.org/10.1371/journal.pone.0118401.g001

For a direct functional analysis of Stat3 activation in intestinal epithelial cells during gastrointestinal infections, IEC-specific Stat3 deficient mice (Stat3^ΔIEC) and control littermates (Stat3^fl/fl) were challenged with C. rodentium. The efficiency of conditional Stat3 deletion was confirmed by histological staining of colon samples derived from infected control and Stat3^ΔIEC mice: while colonic tissue of infected control mice showed activated Stat3 in both lamina propria and colonic epithelial cells as demonstrated above, phosphorylated Stat3 was detectable in lamina propria cells but not IECs of infected Stat3^ΔIEC mice (Fig. 2a). IEC-specific Stat3 conditional knockout mice were highly susceptible to C. rodentium infection. Stat3^ΔIEC mice significantly lost more body weight than controls and showed a general deterioration in health of these animals, as evidenced by a lack of activity and ruffled fur (Fig. 2b). While control mice developed mild intestinal inflammation, infected Stat3^ΔIEC mice showed severe signs of colonic inflammation with high granularity, strong formation of fibrin and diarrhea (Fig. 2c). The difference in extent of colitis was confirmed by statistical analysis of endoscopic colitis scores (Fig. 2c). In agreement with endoscopic analysis, immunofluorescence stainings of gut cross-sections revealed prominent infiltrations of CD4 positive and CD11c positive immune cells into the lamina propria of infected Stat3^ΔIEC mice (Fig. 2d). Moreover, Stat3^ΔIEC mice showed increased expression of inflammatory cytokines such as IL-1α, IL-1β, IL-6 and TNF-α (Fig. 2e). Together, our results show that a defect in activating Stat3 in intestinal epithelial cells leads to the development of a strikingly more severe intestinal inflammation after infection with C. rodentium as compared to wildtype mice.

Download:

Fig 2. Stat3^ΔIEC mice are hypersusceptible to C. infection and develop severe colitis.

A) Immunofluorescence staining detecting pStat3 (red) in colon cross-sections of wildtype and Stat3^ΔIEC mice infected with C. rodentium demonstrates absence of activated Stat3 in intestinal epithelial cells of Stat3^ΔIEC mice during infection with C. rodentium. Nuclei were counterstained with Hoechst (blue). Scale bars: 100 μm. B) Body weights of control and Stat3^ΔIEC mice were monitored during the course of infection and calculated relative to day 0. Data show mean values +/- SEM (n = 4 control mice, n = 6 Stat3^ΔIEC mice). C) Left: Endoscopic pictures of C. rodentium infected control and Stat3^ΔIEC mice show severe signs of colonic inflammation in infected Stat3^ΔIEC mice. Right: Severity of colitis was quantified by endoscopic scoring. Data show mean values + SEM (n = 3 mice in each group). D) Left: Representative pictures of colonic cross-sections derived from infected control and Stat3^ΔIEC mice stained for CD4 (red), CD11c (red) and MPO (red). Nuclei were stained with Hoechst (blue). Scale bars: 200 μm. Right: Software-based calculation of the proportion of CD4⁺ cells, CD11c⁺ cells, and MPO⁺ cells in immunofluorescence pictures stained for the designated cells. Data show mean values + SEM. E) Transcription of cytokines in the colon of C. rodentium infected control and Stat3^ΔIEC mice. Data were calculated relative to infected control and show mean values + SEM (n = 4 mice in each group). Hprt was used as internal standard. Four independent experiments were performed with similar results on each occasion.

https://doi.org/10.1371/journal.pone.0118401.g002

In line with increased intestinal inflammation in Stat3^ΔIEC mice, we detected enlarged infection loads of C. rodentium by in vivo imaging in the gut of these mice (Fig. 3a). To investigate bacterial colonization of the gut in a more detailed fashion, we performed FISH (fluorescence in situ hybridization) of colonic cross-sections and observed an increased amount of bacteria directly adherent to the intestinal epithelial surface (Fig. 3b). Remarkably, in contrast to control mice, where bacteria remained on the surface of the epithelial brush border, bacteria in infected Stat3^ΔIEC deficient mice penetrated deeply into the crypts. These data suggest the inflammatory phenotype observed in infected Stat3^ΔIEC mice to be aggravated by the excessively increased amount of bacteria adherent to the bowel wall and indicate defects in intestinal epithelial barrier function.

Download:

Fig 3. Breakdown of intestinal epithelial barrier in infected Stat3^ΔIEC mice facilitates systemic spread of C. rodentium.

A) Left: Visualization of luminescent C. rodentium in live mice by IVIS on day six after infection. Right: Quantification of C. rodentium infestation by measuring C. rodentium luminescence at different time points after infection of control and Stat3^ΔIEC mice. Data show mean values + SEM (n = 5 mice in each group). B) Fluorescence in situ hybridization (FISH) of bacterial RNA (red) present in colonic cross-section. Nuclei are shown in blue. Scale bars: 50 μm. C) H&E staining of colonic cross-sections from infected control and Stat3^ΔIEC mice. Scale bars: 200 μm. D) Colon cross-sections derived from C. rodentium infected control and Stat3^ΔIEC mice were stained for cell death by TUNEL (green). Nuclei were counterstained with Hoechst (blue). Scale bars: 200 μm. E) C. rodentium infestation of different organs in infected control and Stat3^ΔIEC mice was assessed by plating organ lysates on agar plates (luminescent CFU indicate C. rodentium colonies) (left) and counting luminescent CFUs (right) the next day. Data show mean values + SEM (n = 5 control mice, n = 4 Stat3^ΔIEC mice). Representative pictures are shown.

https://doi.org/10.1371/journal.pone.0118401.g003

In fact, we demonstrate a disrupted intestinal surface epithelium in the colon of infected Stat3^ΔIEC mice by H&E staining (Fig. 3c). Since C. rodentium can induce apoptosis in intestinal epithelial cell lines [22], we investigated whether C. rodentium infected Stat3^ΔIEC mice show increased epithelial cell death. TUNEL (TdT-mediated dUTP nick-end labeling) staining revealed excessive cell death of intestinal epithelial cells in C. rodentium infected Stat3^ΔIEC mice (Fig. 3d). Cell death predominantly occurred within the surface epithelium of C. rodentium infected Stat3^ΔIEC mice directly exposed to the lumen, suggesting that Stat3 is required to control C. rodentium induced epithelial cell death and to maintain barrier integrity.

A serious complication of human gastrointestinal infections is systemic spread. To investigate whether the proposed barrier defects lead to translocation of bacteria from the lumen into the bowel wall and to distant sites, we harvested spleen, liver, and lung tissue and plated homogenized samples on LB-agar plates. Although C. rodentium has been reported to be a non-invasive pathogen [23], invasion of C. rodentium into all investigated organs of Stat3^ΔIEC mice was observed (Fig. 3e). In line with this observation, Stat3^ΔIEC mice not only showed severe intestinal inflammation but signs of sepsis such as dramatic weight loss, ruffled fur and lack of physical activity.

Collectively, these data demonstrate the essential requirement of Stat3 activation in IECs for the control of C. rodentium growth and for maintaining intestinal epithelial barrier function to prevent systemic spreading of bacteria.

The increased population of C. rodentium in Stat3^ΔIEC mice suggested an impaired antimicrobial defense in the gut of Stat3^ΔIEC mice. We therefore examined the expression of antimicrobial peptides such as RegIIIγ, RegIIIβ, lysozyme, cryptdin, Pla2g5 and Pla2g2a in the gut of control and Stat3^ΔIEC mice, under unchallenged conditions and after infection with C. rodentium. Interestingly, unchallenged Stat3^ΔIEC mice lacked expression of RegIIIγ and RegIIIβ in the gut and showed significantly decreased transcription of Pla2g5 compared to unchallenged control mice (Fig. 4a). Infection with C. rodentium significantly induced the transcription of all the investigated antimicrobial peptide genes in the small intestine of control mice. However, induction of most AMPs was abrogated in infected Stat3^ΔIEC mice (Fig. 4a). Since RegIIIγ was recently described to promote host defense against C. rodentium, we next performed immunohistochemistry to investigate RegIIIγ expression in control and conditional Stat3 deficient mice. RegIIIγ was predominantly expressed at the crypt bottom of wildtype mice but was also detected in enterocytes and its expression strongly increased after infection with C. rodentium (Fig. 4b). In contrast, almost no expression of RegIIIγ in the gut of Stat3^ΔIEC mice was observed under unchallenged conditions and only small amounts were detected after infection (Fig. 4b). Thus, we hypothesize that Stat3 activation in IECs may drive the expression of AMPs and thereby controls growth of luminal bacteria.

Download:

Fig 4. Impaired expression of AMPs in Stat3^ΔIEC mice.

A) Quantitative transcription analysis was performed for small intestine of unchallenged control and Stat3^ΔIEC mice and C. rodentium infected (eight days after infection) control and Stat3^ΔIEC mice. Transcription of the antimicrobial peptides lysozyme, RegIIIγ, RegIIIβ, cryptdin, Pla2g5 and Pla2g2a was normalized to Hprt or Villin. Data show mean values + SEM (n = 5 unchallenged control mice, n = 5 unchallenged Stat3^ΔIEC mice, n = 5 C. rodentium infected control mice, n = 4 C. rodentium infected Stat3^ΔIEC mice). B) Representative pictures of small intestinal cross-sections derived from unchallenged and infected control and Stat3^ΔIEC mice were stained for RegIIIγ (red). Nuclei were stained with Hoechst (blue). Scale bars: 50 μm. C) Representative pictures of wildtype organoids treated with or without IL-22 for 24 hours and stained for pStat3 (red) and RegIIIγ (green) using immunohistochemistry. Nuclei were stained with Hoechst (blue). Scale bars: 50 μm. D) Transcription of RegIIIγ in organoids treated with IL-22 for 24 hours or left untreated (n = 6 from 3 different experiments). Gene transcription is normalized to Hprt. Data show mean values + SEM.

https://doi.org/10.1371/journal.pone.0118401.g004

We recently demonstrated Stat3 in intestinal epithelial cells to be activated via stimulation with IL-22 [9]. In agreement with the IL-22—pStat3—pathway driving RegIIIγ expression, phosphorylated Stat3 was detected in organoid epithelial cells simultaneously with high amounts of secreted RegIIIγ after IL-22 treatment (Fig. 4c). In fact, RegIIIγ expression in epithelial organoids was more than 300 fold increased after treatment with IL-22 (Fig. 4d). These data clearly show that IL-22 induces phosphorylation of Stat3 in intestinal epithelial cells followed by production of RegIIIγ.

The data obtained in the present study show that a defect in Stat3 activation leads to an impaired transcription of antimicrobial peptides thereby facilitating overgrowth of C. rodentium. The activation of Stat3 in the intestinal epithelium via IL-22 maintains the epithelial barrier function under stress conditions and prevents translocation of C. rodentium to systemic sites.

Discussion

Intestinal infections lead to production of various cytokines and chemokines by lamina propria immune cells. The secreted cytokines not only influence other immune cells but provide constant information about the gut health status to the epithelial barrier and induce adequate epithelial responses [24]. Maintenance of intact intestinal epithelial barrier function is known to be crucial for combating intestinal infections. Recently, IL-22 has been found to play a major role in infections with the EHEC/EPEC like pathogen C. rodentium in mice [14]. In line with this report, we also demonstrated strong induction of IL-22 in the gut of mice infected with C. rodentium. However, our data go beyond the role of IL-22 and for the first time directly demonstrate a functional role of Stat3 signaling in intestinal epithelial cells for control of gastrointestinal infections in vivo. Our study collectively shows that epithelial Stat3 concerts the host response to bacterial infection by controlling bacterial growth and suppression of apoptosis to sustain intestinal epithelial barrier function. Interestingly, while our data together with the study published by Zheng et al. demonstrate the IL-22—Stat3 axis to be important in combating C. rodentium infections, IL-22 was shown to be detrimental in case of Salmonella enterica serovar Typhimurium infection [25]. It was concluded that IL-22 induced upon S. Typhimurium infection can be exploited by this pathogen to suppress the commensal bacterial flora by induction of antimicrobial peptides responsible for metal ion starvation. A strong impact of antimicrobials induced by Stat3 activation on the gut flora is also supported by our study as unlike control mice, C. rodentium sensitive Stat3^ΔIEC mice showed no induction of RegIIIγ, RegIIIβ and Pla2g2a after infection. Remarkably, expression of RegIIIγ and RegIIIβ was completely diminished in Stat3^ΔIEC mice, indicating that Stat3 is a key regulator of these AMPs. Although these data might indicate impaired killing of C. rodentium in Stat3^ΔIEC mice, an alternative hypothesis is that C. rodentium in Stat3^ΔIEC mice can capture ecological niches that might have developed from altered AMP expression in Stat3 deficient mice, similarly to the study by Behnsen and colleagues [25]. In support of the hypothesis, Zheng and coworkers demonstrated that administration of exogenous mouse or human RegIIIγ, which acts on gram-positive bacteria [26], to IL-22 deficient mice infected with gram-negative C. rodentium, partly protected these mice from gastroenteritis [14]. Interestingly, some patients with inflammatory bowel disease also show decreased expression of some AMPs [27]. However, it is still not clear, whether impaired AMP expression is cause or consequence of the disease. Thus, the present study suggests that at least for infections with gastrointestinal pathogens in mice, deficiency in the production of AMPs predispose to a severe course of the disease.

We hypothesize that the altered expression of antimicrobial peptides in the gut of Stat3^ΔIEC mice favored C. rodentium overgrowth and further might facilitate deep penetration of bacteria into the crypt lumen. Indeed, Stat3^ΔIEC mice showed abundant bacterial invasion into the lower crypt compartment. Usually, the crypt lumen constitutes a rather bacterial free environment [28] whose colonization would cause significant dangers. Our data support this conclusion since spread of C. rodentium to distant organs followed by a septic phenotype was observed in Stat3^ΔIEC mice after infection. Since C. rodentium is described as a non-invasive pathogen [23], we suggested death of Stat3 deficient IECs to cause breakdown of the intestinal epithelial barrier integrity allowing invasion of C. rodentium. However, since increased apoptosis was only detected in infected but not unchallenged Stat3^ΔIEC mice, increased death of Stat3 deficient intestinal epithelial cells might only occur under challenged conditions such as C. rodentium infection. In fact, C. rodentium has been described to induce cell death in intestinal epithelial cell lines [22].

In conclusion, we showed that activation of Stat3 in the intestinal epithelium is a key regulator during gastrointestinal infection. Stat3 activation ameliorates intestinal inflammation and prevents systemic spreading of bacteria by controlling growth of bacteria via regulation of AMP expression and by maintaining intestinal epithelial barrier function (Fig. 5). Thus, Stat3 orchestrates the epithelial response to gastrointestinal infections on multiple levels.

Download:

Fig 5. Model of Stat3 activation in intestinal epithelial cells controlling intestinal infections.

Activation of Stat3 in intestinal epithelial cells controls bacterial growth and prevents systemic spread of bacteria by regulating the transcription of AMPs and maintaining intestinal epithelial barrier function. Black arrows indicate secretion by and effect of IL-22 on cells. Orange arrows indicate effects of Stat3 activation. DC = dendritic cell, IECs = intestinal epithelial cells, IL-22 = Interleukin-22, ILC = innate lymphoid cells, NK = natural killer cell, TH17 = T helper cell 17, DC = dendritic cell, PMN = polymorphonuclear neutrophil.

https://doi.org/10.1371/journal.pone.0118401.g005

Acknowledgments

The authors thank Dr. Christian Riedel (University Ulm) for kindly providing luminescent C. rodentium strain ICC169, Julia Schuster and Christina Lindner for excellent technical assistance.

Author Contributions

Conceived and designed the experiments: NW CB. Performed the experiments: NW GP UB MM EM ML. Analyzed the data: NW MFN CB. Contributed reagents/materials/analysis tools: SW MM ML. Wrote the paper: NW CB.

References

1. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies between 1992 and 2000. Bull World Health Organ. 2003;81: 197–204. pmid:12764516
- View Article
- PubMed/NCBI
- Google Scholar
2. Clarke SC, Haigh RD, Freestone PP, Williams PH. Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev. 2003;16: 365–378. pmid:12857773
- View Article
- PubMed/NCBI
- Google Scholar
3. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2: 123–140. pmid:15040260
- View Article
- PubMed/NCBI
- Google Scholar
4. Robert Koch-Institut. Abschließende Darstellung und Bewertung der epidemiologischen Erkenntnisse im EHEC O104:H4 Ausbruch, Deutschland 2011. Available: http://www.rki.de/DE/Content/InfAZ/E/EHEC/EHEC_O104/EHEC-Abschlussbericht.html. Accessed 26 May 2014.
5. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342: 1930–1936. pmid:10874060
- View Article
- PubMed/NCBI
- Google Scholar
6. Eisenhauer PB, Harwig SS, Lehrer RI. Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun. 1992;60: 3556–3565. pmid:1500163
- View Article
- PubMed/NCBI
- Google Scholar
7. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 1999;163: 6718–6724. pmid:10586069
- View Article
- PubMed/NCBI
- Google Scholar
8. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol. 2005;174: 4901–4907. pmid:15814717
- View Article
- PubMed/NCBI
- Google Scholar
9. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206: 1465–1472. pmid:19564350
- View Article
- PubMed/NCBI
- Google Scholar
10. Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol. 2005;100: 64–72. pmid:15654782
- View Article
- PubMed/NCBI
- Google Scholar
11. Neufert C, Pickert G, Zheng Y, Wittkopf N, Warntjen M, Nikolaev A, et al. Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle. 2010;9: 652–655. pmid:20160497
- View Article
- PubMed/NCBI
- Google Scholar
12. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40: 955–962. pmid:18587394
- View Article
- PubMed/NCBI
- Google Scholar
13. Franke A, Balschun T, Karlsen TH, Hedderich J, May S, Lu T, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008;40: 713–715. pmid:18438405
- View Article
- PubMed/NCBI
- Google Scholar
14. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin- 22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14: 282–289. pmid:18264109
- View Article
- PubMed/NCBI
- Google Scholar
15. Graham AC, Carr KD, Sieve AN, Indramohan M, Break TJ, Berg RE. IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection. PLoS One. 2011;6: e17171. pmid:21347242
- View Article
- PubMed/NCBI
- Google Scholar
16. Zindl CL, Lai JF, Lee YK, Maynard CL, Harbour SN, Ouyang W, et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U S A. 2013;110: 12768–71273. pmid:23781104
- View Article
- PubMed/NCBI
- Google Scholar
17. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008;453: 106–109. pmid:18362914
- View Article
- PubMed/NCBI
- Google Scholar
18. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203: 2271–2279. pmid:16982811
- View Article
- PubMed/NCBI
- Google Scholar
19. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 2008;29: 958–970. pmid:19084435
- View Article
- PubMed/NCBI
- Google Scholar
20. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457: 722–725. pmid:18978771
- View Article
- PubMed/NCBI
- Google Scholar
21. Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Bérard M, Kleinschek M, et al. RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol. 2011;12: 320–326. pmid:21336274
- View Article
- PubMed/NCBI
- Google Scholar
22. Flynn AN, Buret AG. Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection. Microb Pathog. 2008;45: 98–104. pmid:18504087
- View Article
- PubMed/NCBI
- Google Scholar
23. Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci. 2006;1072: 28–38. pmid:17057188
- View Article
- PubMed/NCBI
- Google Scholar
24. Wittkopf N, Neurath MF, Becker C. Immune-epithelial crosstalk at the intestinal surface. J Gastroenterol. 2014;49: 375–387. pmid:24469679
- View Article
- PubMed/NCBI
- Google Scholar
25. Behnsen J, Jellbauer S, Wong CP, Edwards RA, George MD, Ouyang W, et al. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity. 2014;40: 262–273. pmid:24508234
- View Article
- PubMed/NCBI
- Google Scholar
26. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313: 1126–1130. pmid:16931762
- View Article
- PubMed/NCBI
- Google Scholar
27. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A. 2005;102: 18129–18134. pmid:16330776
- View Article
- PubMed/NCBI
- Google Scholar
28. Elphick DA, Mahida YR. Paneth cells: their role in innate immunity and inflammatory disease. Gut. 2005;54: 1802–1809. pmid:16284290
- View Article
- PubMed/NCBI
- Google Scholar
29. Riedel CU, Casey PG, Mulcahy H, O'Gara F, Gahan CG, Hill C. Construction of p16Slux, a Novel Vector for Improved Bioluminescent Labeling of Gram-Negative Bacteria. Appl Environ Microbiol. 2007;73: 7092–7095. pmid:17766445
- View Article
- PubMed/NCBI
- Google Scholar
30. Neurath MF, Wittkopf N, Wlodarski A, Waldner M, Neufert C, Wirtz S, et al. Assessment of tumor development and wound healing using endoscopic techniques in mice. Gastroenterology. 2010;139: 1837–1843. pmid:20955705
- View Article
- PubMed/NCBI
- Google Scholar
31. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459: 262–265. pmid:19329995
- View Article
- PubMed/NCBI
- Google Scholar
32. Becker C, Wirtz S, Blessing M, Pirhonen J, Strand D, Bechthold O, et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest. 2003;112: 693–706. pmid:12952918
- View Article
- PubMed/NCBI
- Google Scholar
33. Rasband WS. ImageJ, U S National Institutes of Health, Bethesda, Maryland, USA. 1997–2008; Available: http://rsb.info.nih.gov/ij/.

[ref1] 1. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies between 1992 and 2000. Bull World Health Organ. 2003;81: 197–204. pmid:12764516
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Clarke SC, Haigh RD, Freestone PP, Williams PH. Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev. 2003;16: 365–378. pmid:12857773
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2: 123–140. pmid:15040260
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Robert Koch-Institut. Abschließende Darstellung und Bewertung der epidemiologischen Erkenntnisse im EHEC O104:H4 Ausbruch, Deutschland 2011. Available: http://www.rki.de/DE/Content/InfAZ/E/EHEC/EHEC_O104/EHEC-Abschlussbericht.html. Accessed 26 May 2014.

[ref5] 5. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342: 1930–1936. pmid:10874060
View Article
PubMed/NCBI
Google Scholar

[15] View Article

[16] PubMed/NCBI

[17] Google Scholar

[ref6] 6. Eisenhauer PB, Harwig SS, Lehrer RI. Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun. 1992;60: 3556–3565. pmid:1500163
View Article
PubMed/NCBI
Google Scholar

[19] View Article

[20] PubMed/NCBI

[21] Google Scholar

[ref7] 7. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 1999;163: 6718–6724. pmid:10586069
View Article
PubMed/NCBI
Google Scholar

[23] View Article

[24] PubMed/NCBI

[25] Google Scholar

[ref8] 8. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol. 2005;174: 4901–4907. pmid:15814717
View Article
PubMed/NCBI
Google Scholar

[27] View Article

[28] PubMed/NCBI

[29] Google Scholar

[ref9] 9. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206: 1465–1472. pmid:19564350
View Article
PubMed/NCBI
Google Scholar

[31] View Article

[32] PubMed/NCBI

[33] Google Scholar

[ref10] 10. Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol. 2005;100: 64–72. pmid:15654782
View Article
PubMed/NCBI
Google Scholar

[35] View Article

[36] PubMed/NCBI

[37] Google Scholar

[ref11] 11. Neufert C, Pickert G, Zheng Y, Wittkopf N, Warntjen M, Nikolaev A, et al. Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle. 2010;9: 652–655. pmid:20160497
View Article
PubMed/NCBI
Google Scholar

[39] View Article

[40] PubMed/NCBI

[41] Google Scholar

[ref12] 12. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40: 955–962. pmid:18587394
View Article
PubMed/NCBI
Google Scholar

[43] View Article

[44] PubMed/NCBI

[45] Google Scholar

[ref13] 13. Franke A, Balschun T, Karlsen TH, Hedderich J, May S, Lu T, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008;40: 713–715. pmid:18438405
View Article
PubMed/NCBI
Google Scholar

[47] View Article

[48] PubMed/NCBI

[49] Google Scholar

[ref14] 14. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin- 22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14: 282–289. pmid:18264109
View Article
PubMed/NCBI
Google Scholar

[51] View Article

[52] PubMed/NCBI

[53] Google Scholar

[ref15] 15. Graham AC, Carr KD, Sieve AN, Indramohan M, Break TJ, Berg RE. IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection. PLoS One. 2011;6: e17171. pmid:21347242
View Article
PubMed/NCBI
Google Scholar

[55] View Article

[56] PubMed/NCBI

[57] Google Scholar

[ref16] 16. Zindl CL, Lai JF, Lee YK, Maynard CL, Harbour SN, Ouyang W, et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U S A. 2013;110: 12768–71273. pmid:23781104
View Article
PubMed/NCBI
Google Scholar

[59] View Article

[60] PubMed/NCBI

[61] Google Scholar

[ref17] 17. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008;453: 106–109. pmid:18362914
View Article
PubMed/NCBI
Google Scholar

[63] View Article

[64] PubMed/NCBI

[65] Google Scholar

[ref18] 18. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203: 2271–2279. pmid:16982811
View Article
PubMed/NCBI
Google Scholar

[67] View Article

[68] PubMed/NCBI

[69] Google Scholar

[ref19] 19. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 2008;29: 958–970. pmid:19084435
View Article
PubMed/NCBI
Google Scholar

[71] View Article

[72] PubMed/NCBI

[73] Google Scholar

[ref20] 20. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457: 722–725. pmid:18978771
View Article
PubMed/NCBI
Google Scholar

[75] View Article

[76] PubMed/NCBI

[77] Google Scholar

[ref21] 21. Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Bérard M, Kleinschek M, et al. RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol. 2011;12: 320–326. pmid:21336274
View Article
PubMed/NCBI
Google Scholar

[79] View Article

[80] PubMed/NCBI

[81] Google Scholar

[ref22] 22. Flynn AN, Buret AG. Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection. Microb Pathog. 2008;45: 98–104. pmid:18504087
View Article
PubMed/NCBI
Google Scholar

[83] View Article

[84] PubMed/NCBI

[85] Google Scholar

[ref23] 23. Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci. 2006;1072: 28–38. pmid:17057188
View Article
PubMed/NCBI
Google Scholar

[87] View Article

[88] PubMed/NCBI

[89] Google Scholar

[ref24] 24. Wittkopf N, Neurath MF, Becker C. Immune-epithelial crosstalk at the intestinal surface. J Gastroenterol. 2014;49: 375–387. pmid:24469679
View Article
PubMed/NCBI
Google Scholar

[91] View Article

[92] PubMed/NCBI

[93] Google Scholar

[ref25] 25. Behnsen J, Jellbauer S, Wong CP, Edwards RA, George MD, Ouyang W, et al. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity. 2014;40: 262–273. pmid:24508234
View Article
PubMed/NCBI
Google Scholar

[95] View Article

[96] PubMed/NCBI

[97] Google Scholar

[ref26] 26. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313: 1126–1130. pmid:16931762
View Article
PubMed/NCBI
Google Scholar

[99] View Article

[100] PubMed/NCBI

[101] Google Scholar

[ref27] 27. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A. 2005;102: 18129–18134. pmid:16330776
View Article
PubMed/NCBI
Google Scholar

[103] View Article

[104] PubMed/NCBI

[105] Google Scholar

[ref28] 28. Elphick DA, Mahida YR. Paneth cells: their role in innate immunity and inflammatory disease. Gut. 2005;54: 1802–1809. pmid:16284290
View Article
PubMed/NCBI
Google Scholar

[107] View Article

[108] PubMed/NCBI

[109] Google Scholar

[ref29] 29. Riedel CU, Casey PG, Mulcahy H, O'Gara F, Gahan CG, Hill C. Construction of p16Slux, a Novel Vector for Improved Bioluminescent Labeling of Gram-Negative Bacteria. Appl Environ Microbiol. 2007;73: 7092–7095. pmid:17766445
View Article
PubMed/NCBI
Google Scholar

[111] View Article

[112] PubMed/NCBI

[113] Google Scholar

[ref30] 30. Neurath MF, Wittkopf N, Wlodarski A, Waldner M, Neufert C, Wirtz S, et al. Assessment of tumor development and wound healing using endoscopic techniques in mice. Gastroenterology. 2010;139: 1837–1843. pmid:20955705
View Article
PubMed/NCBI
Google Scholar

[115] View Article

[116] PubMed/NCBI

[117] Google Scholar

[ref31] 31. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459: 262–265. pmid:19329995
View Article
PubMed/NCBI
Google Scholar

[119] View Article

[120] PubMed/NCBI

[121] Google Scholar

[ref32] 32. Becker C, Wirtz S, Blessing M, Pirhonen J, Strand D, Bechthold O, et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest. 2003;112: 693–706. pmid:12952918
View Article
PubMed/NCBI
Google Scholar

[123] View Article

[124] PubMed/NCBI

[125] Google Scholar

[ref33] 33. Rasband WS. ImageJ, U S National Institutes of Health, Bethesda, Maryland, USA. 1997–2008; Available: http://rsb.info.nih.gov/ij/.

Figures

Abstract

Introduction

Materials and Methods

Mice

Citrobacter rodentium infection and endoscopy

Organoid culture

Expression analysis

Histological examination

Statistical analysis

Results

Discussion

Acknowledgments

Author Contributions

References